Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney V Fletcher

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
AIDS (London, England)|February 20, 2022
Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppressionCourtney V Fletcher, Eugène Kroon, Timothy Schacker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2015
Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function ImpairmentTim R Cressey, Anchalee Avihingsanon, Guttiga Halue, et al.
AIDS Research and Human Retroviruses|September 14, 2019
Pharmacokinetics of Coencapsulated Antiretrovirals with Ingestible SensorsHonghu Liu, Eric Daar, Yan Wang, et al.
Cancer Medicine|November 24, 2023
Chemotherapy in pediatric brain tumor and the challenge of the blood-brain barrierJohid Reza Malik, Anthony T Podany, Parvez Khan, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2020
Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapyLauren R Cirrincione, Anthony T Podany, Joshua P Havens, et al.
Pharmacogenetics and Genomics|August 21, 2020
Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapineDavid W Haas, Anthony T Podany, Yajing Bao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2015
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis PreventionAnthony T Podany, Yajing Bao, Susan Swindells, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infectionThomas B Campbell, Nancy S Shulman, Steven C Johnson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 27, 2018
Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasmaLauren R Cirrincione, Sujan Dilly Penchala, Kimberly K Scarsi, et al.
Ebiomedicine|November 13, 2022
Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trialHonghu Liu, Yan Wang, Yilan Huang, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
AIDS (London, England)|February 20, 2022
Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppressionCourtney V Fletcher, Eugène Kroon, Timothy Schacker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2015
Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function ImpairmentTim R Cressey, Anchalee Avihingsanon, Guttiga Halue, et al.
AIDS Research and Human Retroviruses|September 14, 2019
Pharmacokinetics of Coencapsulated Antiretrovirals with Ingestible SensorsHonghu Liu, Eric Daar, Yan Wang, et al.
Cancer Medicine|November 24, 2023
Chemotherapy in pediatric brain tumor and the challenge of the blood-brain barrierJohid Reza Malik, Anthony T Podany, Parvez Khan, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2020
Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapyLauren R Cirrincione, Anthony T Podany, Joshua P Havens, et al.
Pharmacogenetics and Genomics|August 21, 2020
Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapineDavid W Haas, Anthony T Podany, Yajing Bao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2015
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis PreventionAnthony T Podany, Yajing Bao, Susan Swindells, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infectionThomas B Campbell, Nancy S Shulman, Steven C Johnson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 27, 2018
Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasmaLauren R Cirrincione, Sujan Dilly Penchala, Kimberly K Scarsi, et al.
Ebiomedicine|November 13, 2022
Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trialHonghu Liu, Yan Wang, Yilan Huang, et al.
Pageof 17